Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
A medical device company specializing in cardiac electrophysiology and catheter-based treatments.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart mapping catheter put to the test Results expected Sep 2026 (estimated)
- New heart tool aims to simplify AFib treatment Results expected Dec 2026 (estimated)
- New heart tool aims to make AFib treatment faster and safer Results expected Dec 2026 (estimated)
- New catheter combo aims to keep AFib in check longer Results expected Dec 2026 (estimated)
- New heart procedure aims to zap away atrial fibrillation safely Results expected Jul 2027 (estimated)
-
New heart procedure tested against leading device for AFib control
Disease control Recruiting nowThis study tests a new catheter called VARIPULSE against an already approved one, FARAWAVE, for people with persistent atrial fibrillation (a long-lasting irregular heartbeat). About 466 participants will receive one of the two treatments to see which is safer and better at resto…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 17, 2026 00:00 UTC
-
New catheter treatment for irregular heartbeat under Long-Term review
Disease control Recruiting nowThis study is checking the long-term safety and effectiveness of the VARIPULSE catheter, a device already approved by the FDA, for treating people with a type of irregular heartbeat called paroxysmal atrial fibrillation. About 276 participants who have symptoms and haven't respon…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Can a dual energy catheter tame dangerous heart rhythms?
Disease control Recruiting nowThis trial investigates whether a new dual energy catheter system can safely and effectively treat ventricular arrhythmias—abnormal heart rhythms that can be life-threatening. The system uses both radiofrequency and pulsed field energy to ablate the heart tissue causing the probl…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New heart tool aims to make AFib treatment faster and safer
Disease control Recruiting nowThis study is testing a new system (VARIPULSE catheter and TRUPULSE generator) with updated software to treat atrial fibrillation, a condition where the heart beats irregularly. The goal is to see how well the system works in a real-world setting, measuring procedure times and sa…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New heart device aims to tame persistent AFib
Disease control Recruiting nowThis study is testing a new device called the VARIPULSE catheter system to treat persistent atrial fibrillation, a type of irregular heartbeat. The device uses pulsed field ablation to isolate specific heart veins and may be combined with a procedure to close off a heart pouch to…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New heart tool aims to simplify AFib treatment
Disease control Recruiting nowThis study tests a new system (VARIPULSE catheter and TRUPULSE generator) with updated software for treating persistent atrial fibrillation, a long-lasting irregular heartbeat. About 50 adults aged 18-75 who have not responded to medication will undergo a heart ablation procedure…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
New heart mapping catheter put to the test
Knowledge-focused Recruiting nowThis study is testing a new paddle-shaped catheter designed to map the heart's electrical signals in people with various heart rhythm disorders like atrial fibrillation and ventricular tachycardia. The device has many sensors to create a detailed map of the heart's chambers. The …
Sponsor: Biosense Webster, Inc. • Aim: Knowledge-focused
Last updated Sep 02, 2026 00:00 UTC
-
8,000-Patient study monitors Real-World safety of heart rhythm devices
Knowledge-focused Recruiting nowThis observational study will follow 8,000 people with irregular heartbeats (arrhythmias) who are scheduled for a standard catheter ablation procedure using Biosense Webster devices. Researchers will track safety issues and how well the procedure works in everyday hospital practi…
Sponsor: Biosense Webster, Inc. • Aim: Knowledge-focused
Last updated Aug 30, 2026 00:00 UTC